Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VoxSCAN: Voxelotor on Cerebral Hemodynamics in Sickle Cell Anemia
NCT05018728Phase 2Terminated
- Sponsor
- Emory University
- Start
- Mar 2022
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of voxelotor in sickle cell anemia (SCA), sponsored by Emory University. Started Mar 2022; status: terminated.
02
Drugs
voxelotor
03
Conditions
sickle cell anemia (SCA)
Beyond the preview
Go deeper on NCT05018728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05018728.